Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Azetidinone-retinoid hybrids: synthesis and differentiative effects.

Pori M, Galletti P, Soldati R, Calzà L, Mangano C, Giacomini D.

Eur J Med Chem. 2013;70:857-63. doi: 10.1016/j.ejmech.2013.09.057. Epub 2013 Oct 12.

PMID:
24262378
2.

Synthesis, anticancer activities and molecular modeling studies of novel indole retinoid derivatives.

Gurkan-Alp AS, Mumcuoglu M, Andac CA, Dayanc E, Cetin-Atalay R, Buyukbingol E.

Eur J Med Chem. 2012 Dec;58:346-54. doi: 10.1016/j.ejmech.2012.10.013. Epub 2012 Oct 22.

PMID:
23142674
3.

Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apoptosis-resistant cells.

Simoni D, Roberti M, Invidiata FP, Rondanin R, Baruchello R, Malagutti C, Mazzali A, Rossi M, Grimaudo S, Capone F, Dusonchet L, Meli M, Raimondi MV, Landino M, D'Alessandro N, Tolomeo M, Arindam D, Lu S, Benbrook DM.

J Med Chem. 2001 Jul 5;44(14):2308-18.

PMID:
11428925
4.

Highly twisted adamantyl arotinoids: synthesis, antiproliferative effects and RXR transactivation profiles.

Pérez-Rodríguez S, Ortiz MA, Pereira R, Rodríguez-Barrios F, de Lera AR, Piedrafita FJ.

Eur J Med Chem. 2009 Jun;44(6):2434-46. doi: 10.1016/j.ejmech.2009.01.011. Epub 2009 Jan 20.

5.

Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors.

Galletti P, Quintavalla A, Ventrici C, Giannini G, Cabri W, Penco S, Gallo G, Vincenti S, Giacomini D.

ChemMedChem. 2009 Dec;4(12):1991-2001. doi: 10.1002/cmdc.200900309.

PMID:
19821480
6.

Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.

Carr M, Greene LM, Knox AJ, Lloyd DG, Zisterer DM, Meegan MJ.

Eur J Med Chem. 2010 Dec;45(12):5752-66. doi: 10.1016/j.ejmech.2010.09.033. Epub 2010 Sep 22.

PMID:
20933304
7.

Syntheses, antiproliferative activity and theoretical characterization of acitretin-type retinoids with changes in the lipophilic part.

Magoulas GE, Bariamis SE, Athanassopoulos CM, Haskopoulos A, Dedes PG, Krokidis MG, Karamanos NK, Kletsas D, Papaioannou D, Maroulis G.

Eur J Med Chem. 2011 Feb;46(2):721-37. doi: 10.1016/j.ejmech.2010.12.008. Epub 2010 Dec 14.

PMID:
21208698
8.

[Synthesis of retinoids with a modified polar group and their antitumor activity. Report I].

Deriabina EL, Khodonov AA, Cherevataia GV, Kirillova IuG, Shvets VI, Kostanian IA, Astapova MV, Dranitsyna SM, Starovoĭtova EV.

Bioorg Khim. 1995 Dec;21(12):941-9. Russian.

PMID:
8602891
9.

Monocyclic β-lactams: new structures for new biological activities.

Galletti P, Giacomini D.

Curr Med Chem. 2011;18(28):4265-83. Review.

PMID:
21861821
10.

Synthesis and antiproliferative activity of C-homo-lactam derivatives of 7-deoxycholic acid.

Huang Y, Cui J, Chen S, Gan C, Yao Q, Lin Q.

Bioorg Med Chem Lett. 2013 Apr 1;23(7):2265-7. doi: 10.1016/j.bmcl.2012.08.064. Epub 2012 Aug 24.

PMID:
23466224
11.

[Synthesis and antitumor activity of 5-substituted-2-(pyridyl)benzothiazole compounds].

Liu WH, Chang JX, Liu Y.

Yao Xue Xue Bao. 2013 Jan;48(1):83-8. Chinese.

PMID:
23600146
12.

Synthesis and biological evaluation of a potent salicylihalamide A lactam analogue.

Balan D, Burns CJ, Fisk NG, Hügel H, Huang DC, Segal D, White C, Wagler J, Rizzacasa MA.

Org Biomol Chem. 2012 Oct 28;10(40):8147-53.

PMID:
22964776
13.

Studies on the cytotoxic activity of synthetic 2H-azirine-2-azetidinone compounds.

Maia DP, Wilke DV, Mafezoli J, da Silva Júnior JN, de Moraes MO, Pessoa C, Costa-Lotufo LV.

Chem Biol Interact. 2009 Jul 15;180(2):220-5. doi: 10.1016/j.cbi.2009.02.015. Epub 2009 Mar 11.

PMID:
19497420
14.

Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.

Liao V, Liu T, Codd R.

Bioorg Med Chem Lett. 2012 Oct 1;22(19):6200-4. doi: 10.1016/j.bmcl.2012.08.006. Epub 2012 Aug 9.

PMID:
22932316
15.

Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors.

N'gompaza-Diarra J, Bettayeb K, Gresh N, Meijer L, Oumata N.

Eur J Med Chem. 2012 Oct;56:210-6. doi: 10.1016/j.ejmech.2012.08.033. Epub 2012 Sep 1.

PMID:
22982525
17.
18.

Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth.

Mizuno CS, Paul S, Suh N, Rimando AM.

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7385-7. doi: 10.1016/j.bmcl.2010.10.038. Epub 2010 Oct 14.

19.

The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance.

Greene LM, Nathwani SM, Bright SA, Fayne D, Croke A, Gagliardi M, McElligott AM, O'Connor L, Carr M, Keely NO, O'Boyle NM, Carroll P, Sarkadi B, Conneally E, Lloyd DG, Lawler M, Meegan MJ, Zisterer DM.

J Pharmacol Exp Ther. 2010 Nov;335(2):302-13. doi: 10.1124/jpet.110.170415. Epub 2010 Aug 10.

20.

Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.

Kamal A, Bharathi EV, Reddy JS, Ramaiah MJ, Dastagiri D, Reddy MK, Viswanath A, Reddy TL, Shaik TB, Pushpavalli SN, Bhadra MP.

Eur J Med Chem. 2011 Feb;46(2):691-703. doi: 10.1016/j.ejmech.2010.12.004. Epub 2010 Dec 14.

PMID:
21194809
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk